Copyright © 2013 J. González-Moreno and A. Payeras-Cifre.This is an open access article distributed under theCreativeCommons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Recent developments of newdrugs ’ combinations are changing the treatment paradigm in hepatitis C virus infection.Due to the side effect profile of pegylated interferons, interferon-sparing regimens have become the main target in chronic hepatitis C treatment research. Recent proofs of concept studies have suggested that cure of chronic hepatitis C can be achieved without interferon. The purpose of this paper is to provide an overview of the clinical results recently reporte...
INTRODUCTION: Chronic hepatitis C affects 2.2 - 3% of the world population (130 million - 170 millio...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Objectives: Chronic hepatitis C virus (HCV) infection represents a leading worldwide medical and soc...
Although pegylated interferon-α plus ribavirin has become the standard for treating chronic hepatiti...
OBJECTIVES: Chronic hepatitis C virus (HCV) infection represents a leading worldwide medical and ...
Pegylated interferon α (peginterferon α) plus ribavirin is the present mainstay of treatment for pat...
Hepatitis C virus (HCV) is the leading cause of chronic liver disease, surpassing hepatitis B virus ...
Copyright © 2013 Hee Bok Chae et al. This is an open access article distributed under the Creative C...
Hepatitis C virus (HCV) infection is a major public health problem around the world and it is estima...
Abstract Hepatitis C virus (HCV) infections affect about 170 million individuals worldwide and can b...
It is estimated that currently, in the world, approximately 3% of the population has chronic hepatit...
Treatment of hepatitis C virus infection is currently based on a combination of pegylated interferon...
C1 - Journal Articles RefereedNewly licensed direct acting antivirals for hepatitis C virus HCV are ...
Hepatitis C virus (HCV) infection is an important cause of chronic hepatitis, cirrhosis, hepatocellu...
INTRODUCTION: Chronic hepatitis C affects 2.2 - 3% of the world population (130 million - 170 millio...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Objectives: Chronic hepatitis C virus (HCV) infection represents a leading worldwide medical and soc...
Although pegylated interferon-α plus ribavirin has become the standard for treating chronic hepatiti...
OBJECTIVES: Chronic hepatitis C virus (HCV) infection represents a leading worldwide medical and ...
Pegylated interferon α (peginterferon α) plus ribavirin is the present mainstay of treatment for pat...
Hepatitis C virus (HCV) is the leading cause of chronic liver disease, surpassing hepatitis B virus ...
Copyright © 2013 Hee Bok Chae et al. This is an open access article distributed under the Creative C...
Hepatitis C virus (HCV) infection is a major public health problem around the world and it is estima...
Abstract Hepatitis C virus (HCV) infections affect about 170 million individuals worldwide and can b...
It is estimated that currently, in the world, approximately 3% of the population has chronic hepatit...
Treatment of hepatitis C virus infection is currently based on a combination of pegylated interferon...
C1 - Journal Articles RefereedNewly licensed direct acting antivirals for hepatitis C virus HCV are ...
Hepatitis C virus (HCV) infection is an important cause of chronic hepatitis, cirrhosis, hepatocellu...
INTRODUCTION: Chronic hepatitis C affects 2.2 - 3% of the world population (130 million - 170 millio...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...